|
|
Post by dreamboatcruise on Aug 5, 2014 19:13:23 GMT -5
Anyone care to take the leap and assume there was some logic behind the meaningful drop (down to $7.90) followed by spike up (high of $8.40). Was this the digestion process regarding the MNKD specific news of the day? Does it mean anything?
|
|
|
|
Post by jake10977 on Aug 5, 2014 19:28:06 GMT -5
My guess is initially (me included) saw this as not a huge deal. Was this it? Are they going it alone? Then calmer heads prevailed and said ah but maybe they needed a overseas approved facility. 160 Million per year is a lot of Afrezza at retail prices. Plus the big August 11th "New Developments".....run-up before the possible news? I think so, but if nothing significant is released Monday back down we go imo.
|
|
|
|
Post by chauffe00 on Aug 5, 2014 19:28:35 GMT -5
scare tactics on low volume...
|
|
|
|
Post by kc on Aug 5, 2014 19:28:43 GMT -5
|
|
|
|
Post by dreamboatcruise on Aug 5, 2014 19:57:42 GMT -5
My guess is initially (me included) saw this as not a huge deal. Was this it? Are they going it alone? Then calmer heads prevailed and said ah but maybe they needed a overseas approved facility. 160 Million per year is a lot of Afrezza at retail prices. Plus the big August 11th "New Developments".....run-up before the possible news? I think so, but if nothing significant is released Monday back down we go imo. My read was that it was $160M spread over the 5 year period, not per year. |
|
|
|
Post by samsung2310 on Aug 5, 2014 20:07:35 GMT -5
I've been reading and re-reading this "MannKind has agreed to purchase annual minimum quantities of Insulin under the Supply Agreement of an aggregate of approximately €120.1 million in calendar years 2015 through 2019" There are many scenarios as to the interpretation of this... Perhaps more mind games from Mr.Mann Does it mean Minimum Total payment of 120. 120 every year for 5 years. Then aggregate suggests 120 on average per year. ORAggregate totals over 5 years totalling 120.... As I said the interpretation is hazy. One may read something different from another... Here comes an interesting few days.  Rock on Longs |
|
|
|
Post by liane on Aug 5, 2014 20:09:09 GMT -5
I'd say call IR in the morning.
|
|
|
|
Post by brentie on Aug 5, 2014 20:19:10 GMT -5
Briefs: Mannkind, Tutor Perini, DineEquity By Staff Reports Tuesday, August 5, 2014 MannKind Corp. has signed an agreement with a French company to manufacture insulin for Afrezza, the company’s inhalable insulin that was approved in June for sale in the United States. Under the agreement, Amphastar France Pharmaceuticals S.A.S. will make recombinant human insulin for use in Afrezza from 2015 to 2019. The minimum order is for $161 million in insulin during the five-year period.
The agreement was disclosed in a regulatory filing after markets closed on Tuesday. Shares of MannKind earlier closed down 16 cents, or 1.9 percent. to $8.15 on the Nasdaq. www.sfvbj.com/news/2014/aug/05/briefs-tutor-perini-dineequity/ |
|
|
|
Post by ralphm1999 on Aug 5, 2014 20:33:59 GMT -5
Just checked AH and it jumped back into the high 8.30s. Shorts must have tried to scuttle it but could not find sellers. lol.
|
|
|
|
Post by dreamboatcruise on Aug 5, 2014 20:59:02 GMT -5
Just checked AH and it jumped back into the high 8.30s. Shorts must have tried to scuttle it but could not find sellers. lol. Actually there was a fair amount of the 300+ thousand shares in afterhours that traded below $8, so someone was selling... nervous longs or shorts. |
|
|
|
Post by grease on Aug 5, 2014 21:31:45 GMT -5
Just checked AH and it jumped back into the high 8.30s. Shorts must have tried to scuttle it but could not find sellers. lol. Actually there was a fair amount of the 300+ thousand shares in afterhours that traded below $8, so someone was selling... nervous longs or shorts. Actually there was only about 25,000 shares of the 360,000 that traded below $8.00 |
|
|
|
Post by dreamboatcruise on Aug 5, 2014 21:47:27 GMT -5
Actually there was a fair amount of the 300+ thousand shares in afterhours that traded below $8, so someone was selling... nervous longs or shorts. Actually there was only about 25,000 shares of the 360,000 that traded below $8.00 The lizard stands corrected... I was periodically checking trades in AH and thought I saw more of a jump in shares as the price was down, but I didn't actually go through everything so perhaps I missed some larger blocks that went through when still above $8. Sorry to have spread unsubstantiated info. |
|
|
|
Post by babaoriley on Aug 5, 2014 23:21:07 GMT -5
A/H trading more sporadic by far than regular hours. My guess, nothing to see here, folks, move on.
Or, could have been a move by the shorts to start a panic, not a great time to start a panic, though, as hardly anyone notices A/H trading, and if they do, they usually don't give it much respect.
|
|
|
|
Post by rockyp on Aug 5, 2014 23:40:54 GMT -5
My take on the day's news is pretty bullish. If I "only" had $100 million or so in the bank I wouldn't be signing up to purchase $150 million worth of insulin unless I was pretty darn sure I was going to be getting someone on board to distribute it for me. To me it is a pretty good sign that a partnership deal is close. (If the post about the insiders canceling their planned sales for the rest of the year is also confirmed, that is bullish, too.)
That being said, if any of the folks who are short read the tea leaves the same way, I would expect them to throw everything they have tomorrow to try to scare the market down so they can try to cover what they can. It wouldn't surprise me to see a whole host of negative articles tomorrow. Everything from "this rules out a buy out" to "no Big Pharma wanted to work with them so they had to go to a mom-and-pop insulin shop" to "well it won't be Eli Lilly or Novo to partner since they have their own insulin supply".
It's gonna be a little bumpy, but I bet we will have good news, come Monday. |
|
|
|
Post by babaoriley on Aug 5, 2014 23:55:42 GMT -5
Nice post, rockyp! Our deal with the French firm could be contingent on us signing a partner by such and such a date (pretty soon, though, assuming the French company has to gear up a little to produce exactly what we need). Wonder if the FDA has any right to nose around the French company regarding the manufacture?
Have a different take on A/H trading now: the part where it went down to $7.90, well that didn't mean anything at all, but the part where it recovered, well that's as bullish as all get out! LOL!
|
|
/production/original_573352236.gif)
